Increased expression of fibronectin and its complexes with fibrin was demonstrated using binding of CREKA-Cy5.0 in both the tumour models, in comparison to the non-binding observed in healthy tissues (Fig. 3). The gene discussed is FN1; the disease is neoplasm.